The Pathway to a Universal Influenza Vaccine

Catharine I. Paules; Hilary D. Marston; Robert W. Eisinger; David Baltimore; Anthony S. Fauci

doi:10.1016/j.immuni.2017.09.007

The Pathway to a Universal Influenza Vaccine

Catharine I. Paules
, Hilary D. Marston
, Robert W. Eisinger
, David Baltimore
, Anthony S. Fauci

Research output: Contribution to journal › Article › peer-review

157 Scopus citations

Abstract

Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.

Original language	English (US)
Pages (from-to)	599-603
Number of pages	5
Journal	Immunity
Volume	47
Issue number	4
DOIs	https://doi.org/10.1016/j.immuni.2017.09.007
State	Published - Oct 17 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology
Infectious Diseases

Access to Document

10.1016/j.immuni.2017.09.007

Cite this

@article{69423d772fe64a97aacf3459df81434f,

title = "The Pathway to a Universal Influenza Vaccine",

abstract = "Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.",

author = "Paules, \{Catharine I.\} and Marston, \{Hilary D.\} and Eisinger, \{Robert W.\} and David Baltimore and Fauci, \{Anthony S.\}",

note = "Publisher Copyright: {\textcopyright} 2017",

year = "2017",

month = oct,

day = "17",

doi = "10.1016/j.immuni.2017.09.007",

language = "English (US)",

volume = "47",

pages = "599--603",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - The Pathway to a Universal Influenza Vaccine

AU - Paules, Catharine I.

AU - Marston, Hilary D.

AU - Eisinger, Robert W.

AU - Baltimore, David

AU - Fauci, Anthony S.

PY - 2017/10/17

Y1 - 2017/10/17

N2 - Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.

AB - Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.

UR - https://www.scopus.com/pages/publications/85032837562

UR - https://www.scopus.com/pages/publications/85032837562#tab=citedBy

U2 - 10.1016/j.immuni.2017.09.007

DO - 10.1016/j.immuni.2017.09.007

M3 - Article

C2 - 29045889

AN - SCOPUS:85032837562

SN - 1074-7613

VL - 47

SP - 599

EP - 603

JO - Immunity

JF - Immunity

IS - 4

ER -

The Pathway to a Universal Influenza Vaccine

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this